Primary Peritoneal Carcinoma Recruiting Phase 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03983226Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)Treatment
NCT02124421HOT: HIPEC in Ovarian Cancer as Initial TreatmentTreatment